Uncovering the hidden crisis and why
treatments and insurance coverage are falling short.
BRIDGEWATER, N.J. and NETANYA, Israel, May 23, 2024
/PRNewswire/ --
BACKGROUND
Migraine disease is complex and non-curable, affecting 100 million
adolescents. According to the Cleveland Clinic, 28% of teens have
experienced a migraine. The impact of the disease can result in
severe and consequential gaps in learning, the inability to
participate socially, and long-term socioeconomic consequences.
Studies show that the negative quality of life for these
adolescents is similar to cancer.
Experience the full interactive Multichannel News Release here:
https://www.multivu.com/players/English/9261151-theranica-migraine-disease-treatment-for-adolescents/
Early diagnosis and safe intervention are critical to minimize
the impact on a teen's quality of life and prevent long-term
disability into adulthood linked to mental health issues, such as
anxiety disorder, depression, or PTSD. Yet, until recently,
treatment options forced serious tradeoffs.
Many adolescents and their parents are hesitant to use
prescription drugs due to side effects and issues with
treatment adherence. The majority of prescription medications for
prevention and treatment were not originally developed or evaluated
for adolescents and often come with poor tolerability and
disruptive side effects. These medications also often require adult
supervision and compliance to minimize adverse reactions. One class
of drugs is linked to the increased risk of stroke and myocardial
infarction and several others have the potential to form
cancer-causing chemicals, according to the FDA.
This leaves a pressing need to change the standard of care for
adolescents to manage their migraine disease without drugs or
disruption. Controlling migraine disease in adolescents before they
transition into adulthood is imperative to prevent long-term
negative consequences and improve their quality of life.
The Hidden Crisis:
- Untreated migraine disease as an adolescent increases the risk
of becoming an adult with uncontrolled migraine and correlates to
disability linked to mental health issues such as anxiety disorder,
depression, or PTSD.
- Headaches are one of the top 5 health problems in children and
rank third in ER visits.
- On average, adolescents with migraine disease miss 2x more
school days than those without migraine.
- Adolescents with migraine disease caused considerably higher
annual per capita health care costs than children without a
headache diagnosis.
- Many health plans overlook the efficacy and safety associated
with drug-free treatments, limiting adolescents to prescription
medications for prevention and treatment that carry concerning side
effects and can disrupt daily activities.
- Adolescents aren't empowered to manage their conditions
effectively and ensure that they feel safe and secure in the
treatment options provided, especially as they prepare to navigate
college and careers on their own.
Urgent Call to Action:
The need for non-drug, non-disruptive migraine treatment is now
more important than ever—and should be covered by health plans.
Dr. Karissa Thal discusses the
symptoms, statistics, and treatment options for migraine care,
including the first-of-its-kind REN wearable, a non-drug,
non-disruptive migraine treatment purpose-built for adolescents.
Plus, Courtney Clarke, an
18-year-old college-bound student, shares her personal story of how
migraine has affected her life as an adolescent and how she found a
safe, easy, and effective way to manage her disease.
For more information please
visit: www.theranica.com and information at
The American Migraine Foundation
MORE ABOUT DR. THAL AND COURTNEY CLARKE:
Dr. Karissa Thal is a physician in
State College, Pennsylvania. She
earned her Bachelor of Science from The Schreyer Honors College at
The Pennsylvania State University. She
earned her M.D. at The Penn State College of
Medicine and completed her residency with Penn State Health
at the Mount Nittany Medical Center. During her residency, Dr. Thal
served as Chief Resident and she also received a certificate of
appreciation from the Penn State Navy and ROTC programs,
recognizing her work during the COVID-19 pandemic. She completed a
certificate course in Advanced Headache Diagnosis and Management at
Thomas Jefferson University.
Courtney is a senior in high school. She has been suffering from
chronic migraine disease since her early teens. Courtney and her
parents have tried numerous treatment options throughout her
diagnosis, from drug treatment plans to multiple ER visits. Her
chronic migraine disease has significantly impacted her teenage
years, making her studies, extracurricular activities, and time
with friends and family often challenging. Courtney's struggle
caused her to organize the student group Access, a supportive
community for those with chronic illnesses at her school. She's
also persevered and excelled in academics despite her migraine
challenges. Courtney will be attending the University of Michigan in the fall. She plans to
study nuclear engineering.
Produced for: Theranica
Media Contact:
Jennifer
Sefakis
jennifer@greymattermarketing.com
View original
content:https://www.prnewswire.com/news-releases/theranica-1-in-4-adolescents-suffer-from-migraine-disease-and-are-at-risk-for-long-term-disability-302153498.html
SOURCE Theranica